Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 1

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 1
---

or surviving entity has a class of common equity securities listed on the New York Stock Exchange (the “NYSE”), the NYSE American
or the Nasdaq Stock Market (“Nasdaq”), or listed or quoted on an exchange or quotation system that is a successor to the NYSE,
NYSE American or Nasdaq, we may, at our option, redeem the Series B Preferred Stock for cash, in whole or in part, within 120 days
after the date on which such Change of Control occurred, by paying $25.00 per share, plus any accumulated and unpaid dividends to, but
excluding, the date of redemption. If we have provided or provide notice of our election to redeem the Series B Preferred Stock,
the holders of the Series B Preferred Stock will not be permitted to exercise the conversion right described below. The shares of
Series B Preferred Stock do not have any maturity date and will remain outstanding indefinitely, unless and until we decide to redeem
them or they are converted in connection with a Change of Control by the holders of the Series B Preferred Stock. The shares of Series B
Preferred Stock will have no voting rights, except for limited voting rights if we fail to pay dividends for six or more quarterly periods,
as set forth herein under “Description of Series B Preferred Stock — Voting Rights.”

Upon the occurrence of a Change of Control, as
a result of which, except for limited circumstances described herein, neither we nor the acquiring or surviving entity has a class of
common equity securities listed on the NYSE, the NYSE American or Nasdaq, or listed or quoted on an exchange or quotation system that
is a successor to the NYSE, NYSE American or Nasdaq, each holder of Series B Preferred Stock will have the right to convert some
or all of the Series B Preferred Stock held by such holder into our common stock, $0.001 par value per share, as described herein
under “Description of Series B Preferred Stock — Conversion Right upon a Change of Control,” unless, prior to the
Change of Control Conversion Date (as defined herein), we have provided or provide notice of our election to redeem the Series B
Preferred Stock as described herein under “Description of Series B Preferred Stock — Redemption.”

We elected to be taxed as a REIT for U.S. federal
income tax purposes commencing with our taxable year ended December 31, 2016. To assist us in complying with certain U.S. federal
income tax requirements applicable to REITs, among other purposes, our